Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma

NCT03428373 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma in Relapse
Multiple Myeloma Progression
Multiple Myeloma Stage II
Multiple Myeloma Stage I
Multiple Myeloma With Failed Remission
Multiple Myeloma Stage III

Interventions

DRUG: Rivaroxaban
DRUG: ASA

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]